Omaveloxolone not checked
Biogen · BIIB141 · RTA 408
FollowEvery change as it happens, and a Monday email
Trials
3 active
18 in total · 2 in the EU
What this is
- How it works
- How it works isn't classified yet
- Tested for
- Friedreich Ataxia (2 trials)
- Main trialPhase 3
- “In this study, researchers will learn more about omaveloxolone, also known as BIIB141 or SKYCLARYS®. Omaveloxolone is already approved for people with Friedreich's Ataxia (FA) who are 16 years of age or older. However, it is not yet available for younger teens and children. The main goal of this study is to learn how omaveloxolone affects symptoms of FA and its safety in younger participants between the ages of 2 and 15 years old. The main questions researchers want to answer in this study are: * How does omaveloxolone affect the participants' FA symptoms? * How does the body process…”In the company’s words, NCT06953583 on ClinicalTrials.gov
- Other names
- BIIB141 · SKYCLARYS · RTA 408
Other drugs for Friedreich Ataxia
- NomlabofuspLarimar Therapeutics, Inc. · Phase 3
- VatiquinonePTC Therapeutics · Phase 3
- DT-216P2Design Therapeutics, Inc. · Phase 1/2
- GV101Graviton Bioscience Corporation · Phase 2
- ATI-105Adjuvia Therapeutics, Inc. · Phase 1
- SGT-212Solid Biosciences Inc. · Phase 1
Coming up2
- 16 Nov 2027Phase 3 trial completes · ClinicalTrials.gov
- 4 Jun 2030Phase 1 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials18
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Active, not recruiting | 16 Nov 2027 | A Study to Learn More About the Effects and Long-Term Safety of Omaveloxolone (BIIB141) in Children and Teens With Friedreich's Ataxia | |
| Phase 1Active, not recruiting | 4 Jun 2030 | A Study to Find Out How BIIB141 (Omaveloxolone) is Processed in the Body and to Learn More About Its Safety in Participants With Friedreich's Ataxia Aged 2 to 15 Years Old | |
| Phase 2Completed | 2 Nov 2017 | RTA 408 Capsules in Patients With Mitochondrial Myopathy - MOTOR | |
| Phase 2Completed | 31 Oct 2019 | A Study to Learn About the Effects and Safety of RTA 408 (Omaveloxolone) in People Aged 16 to 40 With Friedreich's Ataxia | |
| Phase 1/2Completed | 9 May 2018 | RTA 408 Capsules in Patients With Melanoma - REVEAL | |
| Phase 1Completed | 1 Apr 2014 | RTA 408 Lotion in Healthy Volunteers | |
| Phase 1Completed | 1 Oct 2015 | RTA 408 in the Treatment of Advanced Solid Tumors (NSCLC & Melanoma) - DISCOVER | |
| Phase 1Completed | 20 Nov 2018 | A Pharmacokinetic Study of Omaveloxolone in Healthy Volunteers | |
| Phase 1Completed | 31 May 2019 | A Human AME Study for Omaveloxolone | |
| Phase 1Completed | 18 Aug 2019 | A Clinical Drug-Drug Interaction (DDI) Study With Omaveloxolone | |
| Phase 1Completed | 27 Jan 2020 | A Pharmacokinetic Study of Omaveloxolone in Subjects With Hepatic Impairment and Normal Hepatic Function | |
| Phase 1Completed | 30 Aug 2023 | An Open-label DDI Study of Omaveloxolone in Healthy Subjects | |
| Phase 1Completed | 1 Sep 2023 | A TQTc Study for Omaveloxolone | |
| Phase 1Completed | 11 Mar 2025 | A Study to Find Out How BIIB141 (Omaveloxolone) Moves From the Blood Into the Breastmilk of Healthy Women Who Are Breastfeeding or Pumping Milk | |
| Phase 1Completed | 19 Aug 2025 | A Study to Learn How BIIB141 (Omaveloxolone) is Processed in the Body When Taken as Capsules Compared to Sprinkled on Yogurt in Healthy Adults Aged 18 to 55 | |
| Phase 1Completed | 16 Oct 2025 | A Study to Learn if Taking BIIB141 (Omaveloxolone) Affects How Omeprazole is Processed in the Body and About BIIB141's Safety in Healthy Adults Aged 18 to 55 | |
| Phase 1Completed | 1 May 2026 | A Study to Learn How the Body Processes BIIB141 (Omaveloxolone) When Taken as a Capsule or as a Tablet Dissolved in Liquid, and to Learn About Its Safety in Healthy Adults Ages 18 to 55 | |
| Phase 4Authorised | not given | Identification of mitochondrial biomarkers reflecting omaveloxolone treatment (in FA patients) |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026